scholarly article | Q13442814 |
P50 | author | Martha Lappas | Q59694807 |
Stella Liong | Q37384832 | ||
P2093 | author name string | Gillian Barker | |
P2860 | cites work | The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway | Q24294986 |
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation | Q24616946 | ||
Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice | Q27438116 | ||
Proteins regulating Ras and its relatives | Q28257295 | ||
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 | Q29617043 | ||
The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic? | Q30404178 | ||
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers | Q33267759 | ||
Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babies | Q33291574 | ||
The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells | Q33587770 | ||
Maternal obesity, inflammation, and developmental programming. | Q33747395 | ||
Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. | Q33888360 | ||
Clinical relevance of KRAS in human cancers | Q33959887 | ||
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development | Q33967144 | ||
Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity | Q33976401 | ||
Maternal gestational weight gain and offspring weight in adolescence | Q34402636 | ||
Obesity and diabetes in the developing world--a growing challenge | Q34603178 | ||
Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta | Q34824188 | ||
Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions | Q34943207 | ||
Chemical biology tools for regulating RAS signaling complexity in space and time | Q35264345 | ||
RAF1 is increased in labouring myometrium and modulates inflammation-induced pro-labour mediators. | Q53194890 | ||
Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis. | Q53289113 | ||
Ras oncogene and inflammation: partners in crime. | Q53674703 | ||
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London | Q57523561 | ||
H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells | Q73202039 | ||
Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissues | Q80157675 | ||
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis | Q80998934 | ||
Maternal obesity and markers of inflammation in pregnancy | Q84021918 | ||
The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes | Q85271008 | ||
Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunction | Q86826605 | ||
Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory" | Q35579461 | ||
An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. | Q35858071 | ||
TNF-α stimulates System A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling | Q36247991 | ||
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. | Q36428213 | ||
Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. | Q36508970 | ||
Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at term | Q36592386 | ||
Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women | Q36656445 | ||
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation | Q36772844 | ||
The effect of maternal obesity on the offspring | Q36887493 | ||
Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells | Q37019981 | ||
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome | Q37091901 | ||
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study | Q37340755 | ||
Weight status in the first 6 months of life and obesity at 3 years of age | Q37386768 | ||
Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer | Q37610817 | ||
Maternal obesity is associated with a lipotoxic placental environment | Q37689149 | ||
TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization | Q37699280 | ||
KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer | Q37923195 | ||
The risk of maternal obesity to the long-term health of the offspring | Q38046263 | ||
Obesity and Placental Function. | Q38687952 | ||
Inflammation as a driver and vulnerability of KRAS mediated oncogenesis | Q38864070 | ||
Future predictions of body mass index and overweight prevalence in Australia, 2005-2025. | Q39738391 | ||
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation | Q39958892 | ||
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. | Q40105282 | ||
Placental Pim-1 expression is increased in obesity and regulates cytokine- and toll-like receptor-mediated inflammation. | Q40208726 | ||
The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity | Q40399733 | ||
Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen. | Q40540260 | ||
Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas | Q40858455 | ||
Sounding the alarm: protein kinase cascades activated by stress and inflammation | Q41106742 | ||
Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53. | Q42208993 | ||
PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes | Q42381281 | ||
Cancer: Drug for an 'undruggable' protein | Q42734596 | ||
Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus | Q43795799 | ||
Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. | Q44575859 | ||
Placental structure and inflammation in pregnancies associated with obesity. | Q46328759 | ||
Identification of human liver cytochrome P450 enzymes responsible for the metabolism of lonafarnib (Sarasar). | Q46916966 | ||
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. | Q47959541 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
immunology | Q101929 | ||
maternal obesity | Q108582152 | ||
P304 | page(s) | 3645386 | |
P577 | publication date | 2018-10-08 | |
P1433 | published in | Mediators of Inflammation | Q2144494 |
P1476 | title | Placental Ras Regulates Inflammation Associated with Maternal Obesity | |
P478 | volume | 2018 |